Home/Filings/4/0000950170-24-040496
4//SEC Filing

Ferrante Karen Jean 4

Accession 0000950170-24-040496

CIK 0001622229other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 6:21 PM ET

Size

5.7 KB

Accession

0000950170-24-040496

Insider Transaction Report

Form 4
Period: 2024-04-01
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-04-01+3,2133,213 total
    Exercise: $6.90From: 2024-04-01Exp: 2034-04-01Common Stock (3,213 underlying)
Footnotes (1)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

Documents

1 file

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001598502

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 6:21 PM ET
Size
5.7 KB